Enhancers of LSD1 interact with lncRNAs and are recruited to the promoter regions of cancer suppressors, such as KLF2, LATS2, and P21, to inhibit their transcriptional activity (Li W. et al., 2016; Zang et al., 2016). The gene discussed is KDM1A; the disease is cancer.